Neuroprotection Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroprotection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Free Anti-Inflammatory Agents
1.2.3 Radical Trapping Agents (Antioxidants)
1.2.4 Apoptosis Inhibitors
1.2.5 Glutamate Antagonists (Anti-Excitotoxic Agents)
1.2.6 Neurotrophic Factors (NTFs)
1.2.7 Stimulants
1.2.8 Metal Ion Chelators
1.2.9 Others
1.3 Market by Application
1.3.1 Global Neuroprotection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Prevention
1.3.3 Treatment
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neuroprotection Market Perspective (2017-2028)
2.2 Neuroprotection Growth Trends by Region
2.2.1 Neuroprotection Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Neuroprotection Historic Market Size by Region (2017-2022)
2.2.3 Neuroprotection Forecasted Market Size by Region (2023-2028)
2.3 Neuroprotection Market Dynamics
2.3.1 Neuroprotection Industry Trends
2.3.2 Neuroprotection Market Drivers
2.3.3 Neuroprotection Market Challenges
2.3.4 Neuroprotection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuroprotection Players by Revenue
3.1.1 Global Top Neuroprotection Players by Revenue (2017-2022)
3.1.2 Global Neuroprotection Revenue Market Share by Players (2017-2022)
3.2 Global Neuroprotection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neuroprotection Revenue
3.4 Global Neuroprotection Market Concentration Ratio
3.4.1 Global Neuroprotection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroprotection Revenue in 2021
3.5 Neuroprotection Key Players Head office and Area Served
3.6 Key Players Neuroprotection Product Solution and Service
3.7 Date of Enter into Neuroprotection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroprotection Breakdown Data by Type
4.1 Global Neuroprotection Historic Market Size by Type (2017-2022)
4.2 Global Neuroprotection Forecasted Market Size by Type (2023-2028)
5 Neuroprotection Breakdown Data by Application
5.1 Global Neuroprotection Historic Market Size by Application (2017-2022)
5.2 Global Neuroprotection Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Neuroprotection Market Size (2017-2028)
6.2 North America Neuroprotection Market Size by Type
6.2.1 North America Neuroprotection Market Size by Type (2017-2022)
6.2.2 North America Neuroprotection Market Size by Type (2023-2028)
6.2.3 North America Neuroprotection Market Share by Type (2017-2028)
6.3 North America Neuroprotection Market Size by Application
6.3.1 North America Neuroprotection Market Size by Application (2017-2022)
6.3.2 North America Neuroprotection Market Size by Application (2023-2028)
6.3.3 North America Neuroprotection Market Share by Application (2017-2028)
6.4 North America Neuroprotection Market Size by Country
6.4.1 North America Neuroprotection Market Size by Country (2017-2022)
6.4.2 North America Neuroprotection Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Neuroprotection Market Size (2017-2028)
7.2 Europe Neuroprotection Market Size by Type
7.2.1 Europe Neuroprotection Market Size by Type (2017-2022)
7.2.2 Europe Neuroprotection Market Size by Type (2023-2028)
7.2.3 Europe Neuroprotection Market Share by Type (2017-2028)
7.3 Europe Neuroprotection Market Size by Application
7.3.1 Europe Neuroprotection Market Size by Application (2017-2022)
7.3.2 Europe Neuroprotection Market Size by Application (2023-2028)
7.3.3 Europe Neuroprotection Market Share by Application (2017-2028)
7.4 Europe Neuroprotection Market Size by Country
7.4.1 Europe Neuroprotection Market Size by Country (2017-2022)
7.4.2 Europe Neuroprotection Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuroprotection Market Size (2017-2028)
8.2 Asia-Pacific Neuroprotection Market Size by Type
8.2.1 Asia-Pacific Neuroprotection Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Neuroprotection Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Neuroprotection Market Share by Type (2017-2028)
8.3 Asia-Pacific Neuroprotection Market Size by Application
8.3.1 Asia-Pacific Neuroprotection Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Neuroprotection Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Neuroprotection Market Share by Application (2017-2028)
8.4 Asia-Pacific Neuroprotection Market Size by Region
8.4.1 Asia-Pacific Neuroprotection Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Neuroprotection Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Neuroprotection Market Size (2017-2028)
9.2 Latin America Neuroprotection Market Size by Type
9.2.1 Latin America Neuroprotection Market Size by Type (2017-2022)
9.2.2 Latin America Neuroprotection Market Size by Type (2023-2028)
9.2.3 Latin America Neuroprotection Market Share by Type (2017-2028)
9.3 Latin America Neuroprotection Market Size by Application
9.3.1 Latin America Neuroprotection Market Size by Application (2017-2022)
9.3.2 Latin America Neuroprotection Market Size by Application (2023-2028)
9.3.3 Latin America Neuroprotection Market Share by Application (2017-2028)
9.4 Latin America Neuroprotection Market Size by Country
9.4.1 Latin America Neuroprotection Market Size by Country (2017-2022)
9.4.2 Latin America Neuroprotection Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuroprotection Market Size (2017-2028)
10.2 Middle East & Africa Neuroprotection Market Size by Type
10.2.1 Middle East & Africa Neuroprotection Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Neuroprotection Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Neuroprotection Market Share by Type (2017-2028)
10.3 Middle East & Africa Neuroprotection Market Size by Application
10.3.1 Middle East & Africa Neuroprotection Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Neuroprotection Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Neuroprotection Market Share by Application (2017-2028)
10.4 Middle East & Africa Neuroprotection Market Size by Country
10.4.1 Middle East & Africa Neuroprotection Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Neuroprotection Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Neuroprotection Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Neuroprotection Business (2017-2022)
11.1.5 F. Hoffmann-La Roche Recent Developments
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Neuroprotection Introduction
11.2.4 Eli Lilly and Company Revenue in Neuroprotection Business (2017-2022)
11.2.5 Eli Lilly and Company Recent Developments
11.3 Daiichi Sankyo Company
11.3.1 Daiichi Sankyo Company Company Details
11.3.2 Daiichi Sankyo Company Business Overview
11.3.3 Daiichi Sankyo Company Neuroprotection Introduction
11.3.4 Daiichi Sankyo Company Revenue in Neuroprotection Business (2017-2022)
11.3.5 Daiichi Sankyo Company Recent Developments
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan Neuroprotection Introduction
11.4.4 Allergan Revenue in Neuroprotection Business (2017-2022)
11.4.5 Allergan Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Neuroprotection Introduction
11.5.4 Novartis Revenue in Neuroprotection Business (2017-2022)
11.5.5 Novartis Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Neuroprotection Introduction
11.6.4 AstraZeneca Revenue in Neuroprotection Business (2017-2022)
11.6.5 AstraZeneca Recent Developments
11.7 Dr. Reddy's Laboratories
11.7.1 Dr. Reddy's Laboratories Company Details
11.7.2 Dr. Reddy's Laboratories Business Overview
11.7.3 Dr. Reddy's Laboratories Neuroprotection Introduction
11.7.4 Dr. Reddy's Laboratories Revenue in Neuroprotection Business (2017-2022)
11.7.5 Dr. Reddy's Laboratories Recent Developments
11.8 Astrocyte Pharmaceuticals
11.8.1 Astrocyte Pharmaceuticals Company Details
11.8.2 Astrocyte Pharmaceuticals Business Overview
11.8.3 Astrocyte Pharmaceuticals Neuroprotection Introduction
11.8.4 Astrocyte Pharmaceuticals Revenue in Neuroprotection Business (2017-2022)
11.8.5 Astrocyte Pharmaceuticals Recent Developments
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Details
11.9.2 Teva Pharmaceutical Industries Business Overview
11.9.3 Teva Pharmaceutical Industries Neuroprotection Introduction
11.9.4 Teva Pharmaceutical Industries Revenue in Neuroprotection Business (2017-2022)
11.9.5 Teva Pharmaceutical Industries Recent Developments
11.10 Biogen
11.10.1 Biogen Company Details
11.10.2 Biogen Business Overview
11.10.3 Biogen Neuroprotection Introduction
11.10.4 Biogen Revenue in Neuroprotection Business (2017-2022)
11.10.5 Biogen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Neuroprotection Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Free Anti-Inflammatory Agents
Table 3. Key Players of Radical Trapping Agents (Antioxidants)
Table 4. Key Players of Apoptosis Inhibitors
Table 5. Key Players of Glutamate Antagonists (Anti-Excitotoxic Agents)
Table 6. Key Players of Neurotrophic Factors (NTFs)
Table 7. Key Players of Stimulants
Table 8. Key Players of Metal Ion Chelators
Table 9. Key Players of Others
Table 10. Global Neuroprotection Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 11. Global Neuroprotection Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 12. Global Neuroprotection Market Size by Region (2017-2022) & (US$ Million)
Table 13. Global Neuroprotection Market Share by Region (2017-2022)
Table 14. Global Neuroprotection Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 15. Global Neuroprotection Market Share by Region (2023-2028)
Table 16. Neuroprotection Market Trends
Table 17. Neuroprotection Market Drivers
Table 18. Neuroprotection Market Challenges
Table 19. Neuroprotection Market Restraints
Table 20. Global Neuroprotection Revenue by Players (2017-2022) & (US$ Million)
Table 21. Global Neuroprotection Revenue Share by Players (2017-2022)
Table 22. Global Top Neuroprotection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroprotection as of 2021)
Table 23. Ranking of Global Top Neuroprotection Companies by Revenue (US$ Million) in 2021
Table 24. Global 5 Largest Players Market Share by Neuroprotection Revenue (CR5 and HHI) & (2017-2022)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Neuroprotection Product Solution and Service
Table 27. Date of Enter into Neuroprotection Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Neuroprotection Market Size by Type (2017-2022) & (US$ Million)
Table 30. Global Neuroprotection Revenue Market Share by Type (2017-2022)
Table 31. Global Neuroprotection Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 32. Global Neuroprotection Revenue Market Share by Type (2023-2028)
Table 33. Global Neuroprotection Market Size by Application (2017-2022) & (US$ Million)
Table 34. Global Neuroprotection Revenue Share by Application (2017-2022)
Table 35. Global Neuroprotection Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 36. Global Neuroprotection Revenue Share by Application (2023-2028)
Table 37. North America Neuroprotection Market Size by Type (2017-2022) & (US$ Million)
Table 38. North America Neuroprotection Market Size by Type (2023-2028) & (US$ Million)
Table 39. North America Neuroprotection Market Size by Application (2017-2022) & (US$ Million)
Table 40. North America Neuroprotection Market Size by Application (2023-2028) & (US$ Million)
Table 41. North America Neuroprotection Market Size by Country (2017-2022) & (US$ Million)
Table 42. North America Neuroprotection Market Size by Country (2023-2028) & (US$ Million)
Table 43. Europe Neuroprotection Market Size by Type (2017-2022) & (US$ Million)
Table 44. Europe Neuroprotection Market Size by Type (2023-2028) & (US$ Million)
Table 45. Europe Neuroprotection Market Size by Application (2017-2022) & (US$ Million)
Table 46. Europe Neuroprotection Market Size by Application (2023-2028) & (US$ Million)
Table 47. Europe Neuroprotection Market Size by Country (2017-2022) & (US$ Million)
Table 48. Europe Neuroprotection Market Size by Country (2023-2028) & (US$ Million)
Table 49. Asia Pacific Neuroprotection Market Size by Type (2017-2022) & (US$ Million)
Table 50. Asia Pacific Neuroprotection Market Size by Type (2023-2028) & (US$ Million)
Table 51. Asia Pacific Neuroprotection Market Size by Application (2017-2022) & (US$ Million)
Table 52. Asia Pacific Neuroprotection Market Size by Application (2023-2028) & (US$ Million)
Table 53. Asia Pacific Neuroprotection Market Size by Region (2017-2022) & (US$ Million)
Table 54. Asia Pacific Neuroprotection Market Size by Region (2023-2028) & (US$ Million)
Table 55. Latin America Neuroprotection Market Size by Type (2017-2022) & (US$ Million)
Table 56. Latin America Neuroprotection Market Size by Type (2023-2028) & (US$ Million)
Table 57. Latin America Neuroprotection Market Size by Application (2017-2022) & (US$ Million)
Table 58. Latin America Neuroprotection Market Size by Application (2023-2028) & (US$ Million)
Table 59. Latin America Neuroprotection Market Size by Country (2017-2022) & (US$ Million)
Table 60. Latin America Neuroprotection Market Size by Country (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Neuroprotection Market Size by Type (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Neuroprotection Market Size by Type (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Neuroprotection Market Size by Application (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Neuroprotection Market Size by Application (2023-2028) & (US$ Million)
Table 65. Middle East and Africa Neuroprotection Market Size by Country (2017-2022) & (US$ Million)
Table 66. Middle East and Africa Neuroprotection Market Size by Country (2023-2028) & (US$ Million)
Table 67. F. Hoffmann-La Roche Company Details
Table 68. F. Hoffmann-La Roche Business Overview
Table 69. F. Hoffmann-La Roche Neuroprotection Product
Table 70. F. Hoffmann-La Roche Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
Table 71. F. Hoffmann-La Roche Recent Developments
Table 72. Eli Lilly and Company Company Details
Table 73. Eli Lilly and Company Business Overview
Table 74. Eli Lilly and Company Neuroprotection Product
Table 75. Eli Lilly and Company Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
Table 76. Eli Lilly and Company Recent Developments
Table 77. Daiichi Sankyo Company Company Details
Table 78. Daiichi Sankyo Company Business Overview
Table 79. Daiichi Sankyo Company Neuroprotection Product
Table 80. Daiichi Sankyo Company Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
Table 81. Daiichi Sankyo Company Recent Developments
Table 82. Allergan Company Details
Table 83. Allergan Business Overview
Table 84. Allergan Neuroprotection Product
Table 85. Allergan Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
Table 86. Allergan Recent Developments
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Neuroprotection Product
Table 90. Novartis Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
Table 91. Novartis Recent Developments
Table 92. AstraZeneca Company Details
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Neuroprotection Product
Table 95. AstraZeneca Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
Table 96. AstraZeneca Recent Developments
Table 97. Dr. Reddy's Laboratories Company Details
Table 98. Dr. Reddy's Laboratories Business Overview
Table 99. Dr. Reddy's Laboratories Neuroprotection Product
Table 100. Dr. Reddy's Laboratories Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
Table 101. Dr. Reddy's Laboratories Recent Developments
Table 102. Astrocyte Pharmaceuticals Company Details
Table 103. Astrocyte Pharmaceuticals Business Overview
Table 104. Astrocyte Pharmaceuticals Neuroprotection Product
Table 105. Astrocyte Pharmaceuticals Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
Table 106. Astrocyte Pharmaceuticals Recent Developments
Table 107. Teva Pharmaceutical Industries Company Details
Table 108. Teva Pharmaceutical Industries Business Overview
Table 109. Teva Pharmaceutical Industries Neuroprotection Product
Table 110. Teva Pharmaceutical Industries Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
Table 111. Teva Pharmaceutical Industries Recent Developments
Table 112. Biogen Company Details
Table 113. Biogen Business Overview
Table 114. Biogen Neuroprotection Product
Table 115. Biogen Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
Table 116. Biogen Recent Developments
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuroprotection Market Share by Type: 2021 VS 2028
Figure 2. Free Anti-Inflammatory Agents Features
Figure 3. Radical Trapping Agents (Antioxidants) Features
Figure 4. Apoptosis Inhibitors Features
Figure 5. Glutamate Antagonists (Anti-Excitotoxic Agents) Features
Figure 6. Neurotrophic Factors (NTFs) Features
Figure 7. Stimulants Features
Figure 8. Metal Ion Chelators Features
Figure 9. Others Features
Figure 10. Global Neuroprotection Market Share by Application: 2021 VS 2028
Figure 11. Prevention Case Studies
Figure 12. Treatment Case Studies
Figure 13. Neuroprotection Report Years Considered
Figure 14. Global Neuroprotection Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Neuroprotection Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Neuroprotection Market Share by Region: 2021 VS 2028
Figure 17. Global Neuroprotection Market Share by Players in 2021
Figure 18. Global Top Neuroprotection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroprotection as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Neuroprotection Revenue in 2021
Figure 20. North America Neuroprotection Market Size YoY (2017-2028) & (US$ Million)
Figure 21. North America Neuroprotection Market Size Market Share by Type (2017-2028)
Figure 22. North America Neuroprotection Market Size Market Share by Application (2017-2028)
Figure 23. North America Neuroprotection Market Size Share by Country (2017-2028)
Figure 24. United States Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Neuroprotection Market Size YoY (2017-2028) & (US$ Million)
Figure 27. Europe Neuroprotection Market Size Market Share by Type (2017-2028)
Figure 28. Europe Neuroprotection Market Size Market Share by Application (2017-2028)
Figure 29. Europe Neuroprotection Market Size Share by Country (2017-2028)
Figure 30. Germany Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. France Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. U.K. Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Italy Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Russia Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Nordic Countries Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Neuroprotection Market Size YoY (2017-2028) & (US$ Million)
Figure 37. Asia Pacific Neuroprotection Market Size Market Share by Type (2017-2028)
Figure 38. Asia Pacific Neuroprotection Market Size Market Share by Application (2017-2028)
Figure 39. Asia Pacific Neuroprotection Market Size Share by Region (2017-2028)
Figure 40. China Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Japan Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. South Korea Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Southeast Asia Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. India Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Australia Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 46. Latin America Neuroprotection Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Latin America Neuroprotection Market Size Market Share by Type (2017-2028)
Figure 48. Latin America Neuroprotection Market Size Market Share by Application (2017-2028)
Figure 49. Latin America Neuroprotection Market Size Share by Country (2017-2028)
Figure 50. Mexico Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Brazil Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Neuroprotection Market Size YoY (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Neuroprotection Market Size Market Share by Type (2017-2028)
Figure 54. Middle East and Africa Neuroprotection Market Size Market Share by Application (2017-2028)
Figure 55. Middle East and Africa Neuroprotection Market Size Share by Country (2017-2028)
Figure 56. Turkey Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. UAE Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in Neuroprotection Business (2017-2022)
Figure 60. Eli Lilly and Company Revenue Growth Rate in Neuroprotection Business (2017-2022)
Figure 61. Daiichi Sankyo Company Revenue Growth Rate in Neuroprotection Business (2017-2022)
Figure 62. Allergan Revenue Growth Rate in Neuroprotection Business (2017-2022)
Figure 63. Novartis Revenue Growth Rate in Neuroprotection Business (2017-2022)
Figure 64. AstraZeneca Revenue Growth Rate in Neuroprotection Business (2017-2022)
Figure 65. Dr. Reddy's Laboratories Revenue Growth Rate in Neuroprotection Business (2017-2022)
Figure 66. Astrocyte Pharmaceuticals Revenue Growth Rate in Neuroprotection Business (2017-2022)
Figure 67. Teva Pharmaceutical Industries Revenue Growth Rate in Neuroprotection Business (2017-2022)
Figure 68. Biogen Revenue Growth Rate in Neuroprotection Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Industry Market Size
